Allergy Therapeutics (LSE:AGY) Interest Expense : £-4.11 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Allergy Therapeutics's interest expense for the six months ended in Jun. 2024 was £ -0.92 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was £-4.11 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Allergy Therapeutics's Operating Income for the six months ended in Jun. 2024 was £ -22.55 Mil. Allergy Therapeutics's Interest Expense for the six months ended in Jun. 2024 was £ -0.92 Mil. Allergy Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Allergy Therapeutics Interest Expense Historical Data

The historical data trend for Allergy Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Interest Expense Chart

Allergy Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Expense

Get a 7-Day Free Trial

-0.50

-0.49

-0.67

-2.44

-4.11

Allergy Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-0.47	-0.40	-2.04	-3.19	-0.92

Allergy Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-4.11 Mil.

Allergy Therapeutics (LSE:AGY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Allergy Therapeutics's Interest Expense for the six months ended in Jun. 2024 was £-0.92 Mil. Its Operating Income for the six months ended in Jun. 2024 was £-22.55 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was £28.87 Mil.

Allergy Therapeutics's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Allergy Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Allergy Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AGYTF:USA HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland.

Allergy Therapeutics Headlines

No Headlines